Hospital Administrators Need to Put Patient Safety Above Profits, Health Expert Argues

Article

Sometimes infections can mean bigger financial returns, argues Michael L. Millenson.

In Health Affairs this morning, Michael L. Millenson waxes passionately about the flaws of a healthcare system in which preventable hospital harms still too often occur. And he takes hospital administrators to task by asking if their institutions actually profit when mistakes, such as central-line-associated bloodstream infections, happen. “Do we believe in ‘First, do no harm’? or ‘First, do no unprofitable harm,’ even if it means blurring the moral boundary between filling hospital beds with those we’re trying to help and those who we have just hurt?” he asks.

Millenson, an internationally recognized expert on patient safety, notes that we near the 20th anniversary of the landmark Institute of Medicine study To Err Is Human and, although some improvement seems to have occurred-for instance, every hospital in the country is doing something to reduce preventable harms-he nonetheless loads his opinion piece with links to studies that still tell a somewhat disheartening tale. You can check them out herehereherehere, and here.  

Millenson isn’t blaming hospital administrators, per se, but says that too often it is easier for infection control to become a somewhat routine and dangerously dysfunctional effort. Providers don’t escape blame, either. 

Millenson: “As a study of clinician overconfidence in infection control delicately concluded, providers ‘do not recognize the need for training [for themselves] but express this need for others.’ In that context, we perhaps should not be surprised that 40% of respondents to a recent 

nationwide survey

’ on hospital safety culture agreed that ‘hospital management seems interested in patient safety only after an adverse event happens.’” 

Millenson acknowledges some push-back, noting that the Society for Healthcare Epidemiology of America in 2007 made the case that its members didn’t just add to costs but that there’s a genuine “business case for infection control. A dozen years later, infection control specialists still feel they need ‘an administrative champion,’” Millenson writes. 

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)